Local
Psychedelic mental healthcare for veterans wins bipartisan backing from US House panel
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Iowa Capital Dispatch

NOTE: This story mentions suicide. If you or a loved one needs help during a mental health crisis, call or text 988, or visit 988helpline.org. Help is available for veterans and nonveterans alike. WASHINGTON — Federal regulators could be on the cusp of approving psychedelic-assisted mental health treatment for veterans, but lawmakers asked tough questions Wednesday of Trump administration officials over whether the Department of Veterans Affairs can meet patients’ needs, and if federal law enforcement and health agencies are on the same page. Just over 2 million veterans suffer with treatment-resistant depression, and approximately 180,000 of them would likely meet the criteria for treatment with psychedelic compounds, including MDMA, psilocybin, LSD, DMT and ibogaine, according to the Veterans Health Administration.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Iowa Capital Dispatch



